Back to Browse Journals » Clinical Ophthalmology » Volume 2 » Issue 1

Clinical treatment options for patients with homonymous visual field defects

Authors Alison R Lane, Daniel T Smith, Thomas Schenk

Published Date March 2008 Volume 2008:2(1) Pages 93—102

DOI http://dx.doi.org/10.2147/OPTH.S2371

Published 17 March 2008

Alison R Lane, Daniel T Smith, Thomas Schenk

Cognitive Neuroscience Research Unit, Durham University, Durham, UK

Abstract: The objective of this review is to evaluate treatments for homonymous visual field defects (HVFDs). We distinguish between three treatments: visual restoration training (VRT), optical aids, and compensatory training. VRT is both the most ambitious and controversial approach, aiming to restore portions of the lost visual field. While early studies suggested that VRT can reduce the visual field defect, recent studies using more reliable means of monitoring the patients’ fixation could not confirm this effect. Studies utilizing modern optical aids have reported some promising results, but the extent to which these aids can reliably reduce the patients’ visual disability has yet to be confirmed. Compensatory approaches, which teach patients more effective ways of using their eyes, are currently the only form of treatment for which behavioral improvements have been demonstrated. However, with the exception of one study using a reading training, placebo-controlled clinical evaluation studies are lacking. It is also not yet clear whether the training benefits found in laboratory tasks lead to reliable improvements in activities of daily living and which of the various forms of compensatory training is the most promising. It is therefore too early to recommend any of the currently available treatment approaches.

Keywords: homonymous hemianopia, rehabilitation, treatment outcome

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Continuous 24-hour ocular dimensional profile recording in medically treated normal-tension glaucoma

Lee JWY, Fu L, Shum JWH, Chan JCH, Lai JS

Clinical Ophthalmology 2015, 9:197-202

Published Date: 29 January 2015

Lower irritation microemulsion-based rotigotine gel: formulation optimization and in vitro and in vivo studies

Wang Z, Mu HJ, Zhang XM, Ma PK, Lian SN, Zhang FP, Chu SY, Zhang WW, Wang AP, Wang WY, Sun KX

International Journal of Nanomedicine 2015, 10:633-644

Published Date: 14 January 2015

Causal diagrams and the logic of matched case-control studies [Corrigendum]

Shahar E, Shahar DJ

Clinical Epidemiology 2014, 6:59-60

Published Date: 22 January 2014

Corrigendum

Schneider EW, Johnson MW

Clinical Ophthalmology 2011, 5:1315-1316

Published Date: 16 September 2011

Clinical use of gatifloxacin ophthalmic solution for treatment of bacterial conjunctivitis

Cervantes LJ, Mah FS

Clinical Ophthalmology 2011, 5:495-502

Published Date: 18 April 2011

Corrigendum: Softec HD hydrophilic acrylic intraocular lens: biocompatibility and precision

Espandar L, Sikder S, Moshirfar M

Clinical Ophthalmology 2011, 5:159-160

Published Date: 6 February 2011

Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis

Safaa Sebak, Maryam Mirzaei, Meenakshi Malhotra, et al

International Journal of Nanomedicine 2010, 5:525-532

Published Date: 15 September 2010

Atomic force microscopy probing in the measurement of cell mechanics

Dimitrios Kirmizis, Stergios Logothetidis

International Journal of Nanomedicine 2010, 5:137-145

Published Date: 23 March 2010

Update on thyroid eye disease and management

Erick D Bothun, Ryan A Scheurer, Andrew R Harrison, et al

Clinical Ophthalmology 2009, 3:543-551

Published Date: 15 October 2009

Transdermal buprenorphine – a critical appraisal of its role in pain management

Guy Hans, Dominique Robert

Journal of Pain Research 2009, 2:117-134

Published Date: 15 September 2009